Use of Prohibited Medication, a Potentially Overlooked...

  • Main
  • 2017 / 9
  • Use of Prohibited Medication, a Potentially Overlooked...

Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-Weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-Year-Olds

Gantz, Ira, Sokolova, Liubov, Jain, Lokesh, Iredale, Carol, O'Neill, Edward A., Wei, Ziwen, Lam, Raymond, Suryawanshi, Shailaja, Kaufman, Keith D., Engel, Samuel S., Lai, Eseng
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Therapeutics
DOI:
10.1016/j.clinthera.2017.08.009
Date:
September, 2017
File:
PDF, 428 KB
english, 2017
Conversion to is in progress
Conversion to is failed